← Evidence map

ReviewDermatology and therapy2016

Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials.

Benjamin Farahnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26910853